Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Pictured: 2012 Rock Stars of Science
Announcement
By Allyson Collins, MS, Science Writer/Editor  |  Thursday, December 6, 2012

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: Michael Berger & David Solit
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 26, 2012

At Memorial Sloan Kettering, new technologies to study gene changes in cancer cells are accelerating the development and implementation of more-effective treatments.

Pictured: Scott Lowe
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 19, 2012

In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Pictured: Marc Ladanyi & Snjezana Dogan
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, November 9, 2012

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Pictured: Martin Weiser
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, November 8, 2012

Memorial Sloan Kettering’s colorectal cancer team has developed online prediction tools that assess disease risk following surgery, enabling patients and physicians to make better treatment decisions.

Event
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, November 6, 2012

For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.

Pictured: Ping Chi
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Pictured: Cycle for Survival
Event
By Memorial Sloan Kettering  |  Thursday, October 25, 2012

Organizers expect this year to be the most successful yet for this national indoor team cycling event, which raises funds for rare cancer research at Memorial Sloan Kettering.

Pictured: Lisa DeAngelis
Honor
By Memorial Sloan Kettering  |  Friday, October 19, 2012

Dr. DeAngelis has been elected to the Institute of Medicine (IOM), considered one of the highest honors in the field of health and medicine.

Pictured: Zuckerman Research Center
Announcement
By Media Staff  |  Wednesday, October 17, 2012

Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.

Research
Pictured: Structure of Synthesized Erythropoietin
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, October 8, 2012

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

Pictured: Alexander Rudensky
Announcement
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, September 26, 2012

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.

Center News

Stay Informed

Get the latest information about cancer care and research every month.